Navigation Links
Luminex Corporation First Quarter Earnings Release Scheduled for May 4, 2015
Date:4/13/2015

AUSTIN, Texas, April 13, 2015 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the first quarter ended March 31, 2015 on Monday, May 4, 2015. A press release announcing the results is scheduled for release after the close of trading.

Management will hold a conference call to discuss the operating highlights and financial results for the first quarter ended March 31, 2015 on May 4, 2015, at 4:30 p.m. Eastern time.

The conference call will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the website, go to the About Us section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the call to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the call will be archived for six months on the website using the 'replay' link.

The use of pop-up blocking software may impair your ability to view webcasts. If you use this software, press and hold the CTRL key when you click on the Register button. Please contact your IT group if you are unable to override this feature. Unauthorized recording or downloading of this event is not permitted.

About Luminex Corporation

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP® open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com.

Luminex Corporate Contact:
Harriss Currie, 512.219.8020
Sr. Vice President, Finance and CFO
hcurrie@luminexcorp.com

Luminex Investor Contact:
Matt Norman, 512.219.8020
Manager, Government and Investor Relations
mnorman@luminexcorp.com

Logo - http://photos.prnewswire.com/prnh/20150201/172702LOGO

 


'/>"/>
SOURCE Luminex Corporation
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Technology Selected by Assurex Health
2. Luminex Corporation To Present At Cowen And Company 35th Annual Health Care Conference
3. Luminex Corporation Announces Retirement of Patrick Balthrop, President and CEO
4. Luminex Corporation Third Quarter Earnings Release Scheduled for October 27, 2014
5. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
6. Luminex Is Supporting U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Research Efforts to Control African Ebola Outbreak
7. Luminex Corporation Reports Second Quarter 2014 results
8. Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014
9. Luminex Corporation Reports Third Quarter 2013 Results
10. LUMINEX CORPORATION TO HOST INVESTOR EVENT AT ASSOCIATION FOR MOLECULAR PATHOLOGY ANNUAL MEETING
11. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/11/2019)... ... November 11, 2019 , ... MAPS and ... implementation of joint projects for the benefit of biomedical professionals in the ... professionals to leverage their roles in the research, development, and commercialization activities ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... drug class and have a major impact in the oncology field. While ... need to be overcome. Among these, defining valuable and adapted combination protocols, ...
(Date:11/11/2019)... (PRWEB) , ... November 10, 2019 , ... ... rebranding alongside a redesign of its website , which features over 600 ... from the brand's 35+ year commitment to providing high-quality health and wellness products, ...
Breaking Medicine Technology:
(Date:11/11/2019)... ... 11, 2019 , ... As Americans celebrate Veterans Day and honor the brave ... remember that they also deserve recognition and compassionate care when dealing with an advanced ... is demonstrating its commitment to providing specialized care for Veterans who are facing ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... for improved foodborne illness prevention and urges increased adoption of compliance technology in ... series of vegetable products sold to select retailers in the United States and ...
(Date:11/9/2019)... ... 08, 2019 , ... Mount Sinai Medical-Legal Partnership (MSMLP), an organization formed to ... free special education law and advocacy assistance to families and patients in need. The ... the work of contributions of Blaine (“Fin”) Fogg, who was a member of the ...
(Date:11/7/2019)... ... 07, 2019 , ... , Entomol’s safe and effective, EPA-approved all-natural insect ... a 4 and a 7 hour formulations. , “Entomol helps people live healthier lives ... Virus and Encephalitis, without exposing them to the harmful chemicals found in other repellents,” ...
(Date:11/6/2019)... ... November 06, 2019 , ... SPH Analytics , ... today that 94% of the health insurance plans receiving the highest 4.5- to ... plans, use SPH solutions according to reports recently released by the ...
Breaking Medicine News(10 mins):